MwanzoGUD • TSE
add
Knight Therapeutics Inc
Bei iliyotangulia
$Â 5.34
Bei za siku
$Â 5.26 - $Â 5.35
Bei za mwaka
$Â 5.09 - $Â 6.23
Thamani ya kampuni katika soko
530.55M CAD
Wastani wa hisa zilizouzwa
elfu 65.74
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 92.26M | 13.21% |
Matumizi ya uendeshaji wa biashara | 41.81M | 6.53% |
Mapato halisi | elfu 85.00 | -99.11% |
Kiwango cha faida halisi | 0.09 | -99.23% |
Mapato kwa kila hisa | — | — |
EBITDA | 16.59M | 13.43% |
Asilimia ya kodi ya mapato | 86.02% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 172.32M | 7.75% |
Jumla ya mali | 962.29M | -4.83% |
Jumla ya dhima | 188.38M | -4.12% |
Jumla ya hisa | 773.91M | — |
hisa zilizosalia | 100.80M | — |
Uwiano wa bei na thamani | 0.70 | — |
Faida inayotokana na mali | 0.84% | — |
Faida inayotokana mtaji | 0.97% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | elfu 85.00 | -99.11% |
Pesa kutokana na shughuli | 5.02M | -66.93% |
Pesa kutokana na uwekezaji | 11.53M | -67.76% |
Pesa kutokana na ufadhili | -3.93M | 65.06% |
Mabadiliko halisi ya pesa taslimu | 12.95M | -67.28% |
Mtiririko huru wa pesa | 1.02M | 121.60% |
Kuhusu
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Ilianzishwa
2014
Makao Makuu
Tovuti
Wafanyakazi
725